Future Fields, a Canadian cell-cultured startup based in Edmonton, has raised US$2.2M from three American venture capital firms — Bee Partners, Pioneer Fund, and Narrative Fund. Several private investors also contributed.
The Companies Removing Fetal Bovine Serum to Make Ethical, Slaughter-Free Meat
Last week, GOOD Meat received the first-in-the-world regulatory approval to use fetal bovine serum-free media in its cultivated poultry production process. With this significant milestone in the history of cultivated meat, we discuss the companies paving the way for ethical, slaughter-free meat. Removing fetal bovine serum (FBS) from cultivated meat production has been among the industry’s major challenges. FBS has been the default growth supplement for in vitro cell culture used by academic and industrial researchers and scientists, including in the cellular agriculture space. Ethically problematic Fetal bovine serum is made by harvesting the blood of bovine fetuses taken from pregnant cows during slaughter. Blood from the fetus is drawn out via a closed collection system and then transformed into a serum. FBS contains growth factors, hormones, …